GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Price-to-Owner-Earnings

Perseus Proteomics (TSE:4882) Price-to-Owner-Earnings : (As of Jun. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Price-to-Owner-Earnings?

As of today (2024-06-14), Perseus Proteomics's share price is 円381.00. Perseus Proteomics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Perseus Proteomics's Price-to-Owner-Earnings or its related term are showing as below:


TSE:4882's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.01
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-14), Perseus Proteomics's share price is 円381.00. Perseus Proteomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-95.57. Therefore, Perseus Proteomics's PE Ratio for today is At Loss.

As of today (2024-06-14), Perseus Proteomics's share price is 円381.00. Perseus Proteomics's EPS without NRI for the trailing twelve months (TTM) ended in was 円-81.26. Therefore, Perseus Proteomics's PE Ratio without NRI for today is At Loss.


Perseus Proteomics Price-to-Owner-Earnings Historical Data

The historical data trend for Perseus Proteomics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Price-to-Owner-Earnings Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Perseus Proteomics Quarterly Data
Mar18 Mar19 Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Perseus Proteomics's Price-to-Owner-Earnings

For the Drug Manufacturers - General subindustry, Perseus Proteomics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perseus Proteomics's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perseus Proteomics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Perseus Proteomics's Price-to-Owner-Earnings falls into.



Perseus Proteomics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Perseus Proteomics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=381.00/-62.14
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Perseus Proteomics  (TSE:4882) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Perseus Proteomics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Perseus Proteomics (TSE:4882) Business Description

Traded in Other Exchanges
N/A
Address
4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines